Author:
Owens Trudy,Evangelou Nikos,Whynes David K.
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference53 articles.
1. Compston, A., Coles, A.: Multiple sclerosis. Lancet 372, 1502–1517 (2008)
2. Berger, T.: Current therapeutic recommendations in multiple sclerosis. J. Neurol. Sci. 287(Supplement 1), S37–S45 (2009)
3. Kobelt, G., Berg, J., Lindgren, P., Kerrigan, J., Russell, N., Nixon, R.: Costs and quality of life of multiple sclerosis in the United Kingdom. Eur. J. Health Econ. 7, S96–S104 (2006)
4. Richards, M.: Extent and causes of international variations in drug usage: a report for the secretary of state for health. Central Office of Information, London (2010)
5. Tolley, K.H., Whynes, D.K.: Interferon-β in multiple sclerosis: can we control its costs ? Pharmacoeconomics 11(3), 210–215 (1997)
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献